Video Experimental Relacionado
Updated: Aug 10, 2026
09:05
Measurement of Smooth Muscle Function in the Isolated Tissue Bath-applications to Pharmacology Research
Published on: January 19, 2015
Efecto de la serotonina, el tromboxano A2 y los antagonistas específicos de los receptores en la proliferación de las
R Pakala1, J T Willerson, C R Benedict
1Department of Internal Medicine, University of Texas Houston Medical School, 77030, USA.
Circulation
|October 23, 1997
Resumen
La serotonina (5-HT) y el tromboxano A2 (TXA2) promueven sinérgicamente la proliferación de las células del músculo liso, un factor clave en la restenosis después de la angioplastia. El bloqueo de las vías 5-HT2 y TXA2 puede prevenir esta proliferación.
Área de la Ciencia:
- Biología Cardiovascular Biología Cardiovascular
- La medicina vascular es una medicina vascular.
- Farmacología Farmacología.
Sus antecedentes:
- La restenosis después de la angioplastia coronaria es un desafío clínico significativo.
- La migración y la proliferación de las células del músculo liso vascular (SMC, por sus siglas en inglés) son mecanismos críticos que impulsan la restenosis.
- Las plaquetas liberan serotonina (5-HT) y tromboxano A2 (TXA2) en los sitios de lesión vascular, lo que sugiere sus roles potenciales en la activación de la SMC.
Objetivo del estudio:
- Para investigar si la serotonina (5-HT) y el tromboxano A2 (TXA2) inducen la proliferación de SMC.
- Para determinar si hay una interacción sinérgica entre 5-HT y TXA2 en la promoción de la proliferación de SMC.
- Evaluar el potencial de dirigirse a estos mediadores para la prevención de la restenosis.
Principales métodos:
- Las SMCs aórticas caninas se cultivaron en un medio libre de suero.
- La proliferación celular se evaluó utilizando la incorporación de [3H]timidina y el recuento celular directo.
- Se evaluaron los efectos de 5-HT, TXA2 mimético (U46619), y sus combinaciones.
- Los antagonistas específicos de los receptores (5-HT2 antagonista LY281067) y los inhibidores / antagonistas (TXA2 inhibidor de la sintasa / receptor antagonista ridogrel) se utilizaron para dilucidar los mecanismos.
Principales resultados:
- Tanto el 5-HT como el TXA2 indujeron la proliferación de SMC a 100 nmol/L.
- Se observó una interacción sinérgica entre 5-HT y TXA2, que mejora la proliferación incluso en concentraciones por debajo del umbral.
- Un antagonista del receptor 5-HT2 bloqueó el efecto del 5-HT y la interacción sinérgica, mientras que un inhibidor/antagonista de TXA2 bloqueó el efecto del TXA2 y la interacción.
- El bloqueo combinado de ambas vías eliminó por completo los efectos mitogénicos.
Conclusiones:
- Los mediadores no peptídicos como 5-HT y TXA2 juegan un papel importante en la proliferación de SMC inducida por plaquetas en los sitios de lesión vascular.
- La inhibición farmacológica combinada de los receptores 5-HT2 y las vías TXA2 es prometedora para atenuar la restenosis post-angioplastia.
Más Videos Relacionados
06:14Murine Aortic Crush Injury: An Efficient In Vivo Model of Smooth Muscle Cell Proliferation and Endothelial Function
Published on: June 11, 2017
08:28Isolation of Primary Patient-specific Aortic Smooth Muscle Cells and Semiquantitative Real-time Contraction Measurements In Vitro
Published on: February 15, 2022
Videos de Conceptos Relacionados
01:17Intracellular Signaling Affects Focal Adhesions
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
01:18Antihypertensive Drugs: Action of Calcium Channel Blockers
Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
01:23Antihypertensive Drugs: Vasodilators
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
01:16Vascular Spasm
The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last for...
01:23Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...